The Efficacy of Vaginal Suppository Based on Alcea angulata Freyn & Sint. (A Persian Medicine Product) in Patients with Vaginal Atrophy: A Randomized, Double-Blind, Placebo-Controlled Trial
-
Alieh Kianitalaei
,
Zohre Feyzabadi
,
Nasser Behnampour
,
Shokuhsadat Hamedi
,
Faride Akhlaghi
,
Marzieh Qaraaty
Abstract
Vaginal atrophy is one of the most common complaints in postmenopausal women. Symptoms of vaginal atrophy include dryness, itching, bleeding, and dyspareunia. According to Traditional Persian Medicine (TPM), the using of moisturizing plants can treat dry mucous membranes. TPM suggests the use of marshmallow (Alcea angulata) to moisturize dry cells with its mucilage. The aim of this study was to evaluate the effect of Alcea on the treatment of vaginal atrophy. This double-blind, clinical trial was conducted on 60 postmenopausal women with vaginal atrophy (40 – 65 years of age). The patients were randomly assigned into two groups of treatment and control (n = 30). The treatment group received Alcea vaginal suppository 5% (125 mg), and the control group received placebo. Both groups used suppositories every night for two weeks and every other night for six weeks. Vaginal Maturation Value (VMV), symptoms of vaginal atrophy, and pH were compared before and after the intervention. Data were analyzed using SPSS 16. VMV was increased in the treatment group, from 40.30 ±13.27 to 46.40 ± 11.27, (p ˂ 0.0001) compared to the control group, in which the change of VMV was not significant (p = 0.122). The vaginal pH was significantly decreased in the treatment group, from 6.45 ± 0.92 to 5.52 ± 0.62, (p ˂ 0.0001) compared to the control group, in which the change of pH was not significant (p ˂ 0.257). The symptoms were significantly reduced in the treatment group. It seems that Alcea vaginal suppository can be useful as a natural product to relieve the symptoms of vaginal atrophy.
Kingsberg S, Kellogg S, Krychman. Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy. Int J Womens Health 2009;1:105-111.
Novak E. Berek & Novak's Gynecology. Lippincott Williams & Wilkins 2007.
Castelo-Branco C, Biglia N, Nappi RE, Schwenkhagen A, Palacios S. Characteristics of post-menopausal women with genitourinary syndrome of menopause: Implications for vulvovaginal atrophy diagnosis and treatment selection. Maturitas 2015;81:462-469.
Cagnacci A, Gallo M, Gambacciani M, Lello S. Correction to: joint recommendations for the diagnosis and treatment of vulvo-vaginal atrophy in women in the peri- and post-menopausal phases from the Societa Italiana per la Menopausa (SIM) and the Societa Italiana della Terza Eta (SIGiTE). Minerva Ginecol 2019;71:345-352.
Palma F, Xholli A, Cagnacci A. The most bothersome symptom of vaginal atrophy: evidence from the observational AGATA study. Maturitas 2018;108:18-23.
Nappi RE, Palacios S, Particco M, Panay N. The REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: country-specific comparisons of postmenopausal women’s perceptions, experiences and needs. Maturitas 2016;91:81-90.
Rahn DD, Carberry C, Sanses TV, Mamik MM, Ward RM et al. Vaginal estrogen for genitourinary syndrome of menopause. Obstet Gynecol 2014;124:1147-1156.
Kelley C. Estrogen and its effect on vaginal atrophy in post-menopausal women.
Urol Nurs 2007;27:40-45.
Palacios S. Managing urogenital atrophy. Maturitas 2009;63:315-318.
Yörük P, Uygur M, Erenus M, Eren F. The role of vaginal maturation value assessment in prediction of vaginal pH, serum FSH and E2 levels. Marmara Med J 2006;19:52-57.
Menopause NAMSJ. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
Menopause 2007;14:355-369.
Rad P, Tadayon M, Abbaspour M, Latifi SM, Rashidi I, et al. The effect of vitamin D on vaginal atrophy in postmenopausal women. Iran J Nurs Midwifery Res 2015;20:211-215.
Golmakani N, Parnan Emamverdikhan A, Zarifian A, Sajadi Tabassi SA, Hassanzadeh M. Vitamin E as alternative local treatment in genitourinary syndrome of menopause: a randomized controlled trial. Int Urogynecol J 2019;30:831-837.
Parnan Emamverdikhan A, Golmakani N, Sharifi Sistani N, Shakeri MT, Hasanzade Mofrad M, et al. Comparing two treatment methods of vitamin E suppository and conjugated estrogen vaginal cream on the quality of life in menopausal women with vaginal atrophy. 2014;2:253-61.
Parnan Emamverdikhan A, Golmakani N, Tabassi SA, Hassanzadeh M, Sharifi N, et al. A survey of the therapeutic effects of Vitamin E suppositories on vaginal atrophy in postmenopausal women. Iran J Nurs Midwifery Res 2016;21:475-481.
Ziagham Z, Abbaspoor Z, Abbaspour M. The comparison between the effects of hyaluronic acid vaginal suppository and vitamin E on the treatment of atrophic vaginitis menopausal women. J Arak Uni Med Sci 2012;15:57-64.
Van der Laak JA, de Bie LM, de Leeuw H, de Wilde PC, Hanselaar A. The effect of Replens® on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. J Clin Pathol 2002;55:446-451.
Beck V, Rohr U, Jungbauer A. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? J Steroid Biochem Mol Biol 2005;94:499-518.
Yaralizadeh M, Abedi P, Najar S, Namjoyan F, Saki A. Effect of foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: a double-blind randomized placebo-controlled trial. Maturitas 2016;84:75-80.
Saffari M. Comparison effects of fenugreek extract vaginal cream and ultra low dose vaginal estrogen on atrophic vaginitis [PhD thesis]. School of Nursing and Midwifery, Tabriz University of Medical Sciences, Iran; 2019.
Di Donato V, D’Oria O, Scudo M, Prata G, Fischetti M, et al. Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: a prospective observational study. Maturitas 2020;135:34-39.
Biglia N, Peano E, Sgandurra P, Moggio G, Panuccio E, et al. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecol Endocrinol 2010;26:404-412.
Lima SMRR, Yamada SS, Reis BF, Postigo S, da Silva MALG, et al. Effective treatment of vaginal atrophy with isoflavone vaginal gel. Maturitas 2013;74:252-258.
Parsons A, Merritt D, Rosen A, Heath III H, Siddhanti S, et al. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy. Obstet Gynecol 2003;101:346-352.
Qaraaty M, Kamali SH, Dabaghian FH, Zafarghandi N, Mokaberinejad R, et al. Effect of myrtle fruit syrup on abnormal uterine bleeding: a randomized double-blind, placebo-controlled pilot study. DARU J Pharm Sci 2014;22:45.
Talebi M, Zarshenas M, Yazdani E, Moein M. Preparation and evaluation of possible antioxidant activities of Rose traditional tablet “[Qurs-e-Vard]” a selected Traditional Persian Medicine [TPM] formulation via various procedures. Curr Drug Discov Technol 2021;18:8.
Avicenna. The Canon of Medicine: Great Books of the Islamic World 1999.
Jean B. Pharmacognosie, phytochimie, plantes médicinales. 4th ed. Lavoisier 2009.
Mozaffarian V. Identification of Medicinal and Aromatic Plants of Iran 2013.
Ziagham S, Abbaspour Z, Abbaspour MR. The comparison betweenthe effects of hyaluronic acid vaginal suppository and vitamin E on the treatment of atrophic vaginitis in menopausal women. J Arak Uni Med Sci 2012;15:57-64.
Nikakhtar Z, Hasanzadeh M, Hamedi SS, Najafi MN, Feyzabadi Z, et al. The efficacy of vaginal suppository based on myrtle in patients with cervicovaginal human papillomavirus infection: a randomized, double‐blind, placebo trial. Phytother Res 2018;32:2002-2008.
Abass H, Kamel R, Abdelbary A. Metronidazole bioadhesive vaginal suppositories: formulation, in vitro and in vivo evaluation. Int J Pharm Pharm Sci 2012;4:344-355.
Yazdani E, Talebi M, Zarshenas M, Moein M. Evaluation of possible antioxidant activities of barberry solid formulation, a selected formulation from Traditional Persian Medicine (TPM) via various procedures. Biointerface Res Appl Chem 2019;9:4517-4521.
Hamedi S, Shams-Ardakani MR, Sadeghpour O, Amin G, Hajighasemali D, et al. Designing mucoadhesive discs containing stem bark extract of Ziziphus jujuba based on Iranian traditional documents. Iranian J Basic Med Sci 2016;19:330-336.
Pharmacopeia U. US Pharmacopeial Convention United States Pharmacopeial Convention. Rockville 2014.
Bachmann G, Bobula J, Mirkin S. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy. Climacteric 2010;13:132-140.
Goudarzi M, Mehrabadi ME, Salemi Z, Amri J, Noori M, et al. Effect of hydroalcoholic extract of allium noeanum Reut. ex Regel on ethylene glycol-induced kidney stone in male wistar rats. Trad Integr Med 2021;6:184-192.
Pakravan M. Fora of Iran. Research Institute of Forests and Rangelands. Tehran 2008.
Pakravan M, Ghahraman A. New species and new records of Alcea for the flora of Iran. 2002.
Deters A, Zippel J, Hellenbrand N, Pappai D, Possemeyer C, et al. Aqueous extracts and polysaccharides from Marshmallow roots (Althea officinalis L.): cellular internalisation and stimulation of cell physiology of human epithelial cells in vitro. J Ethnopharmacol 2010;127:62-69.
Nosal'ova G, Strapkova A, Kardosova A, Capek P, Zathurecký L, et al. Antitussive action of extracts and polysaccharides of marsh mallow (Althea officinalis L., var. robusta). Die Pharmazie 1992;47:224-226.
Al-Snafi AE. Therapeutic properties of medicinal plants: a review of plants with anticancer activity (part 1). Int J Pharm 2015;5:104-124.
Al-Snafi AE. The pharmaceutical importance of althaea officinalis and althaea rosea: a review. Int J Pharmtech Res 2013;5:1378-1385.
Kumar SS, Sudhakar S, Kapil S, Snigdha T. Ethno-pharmacological review on Althaea officinalis. World J Pharm Pharm Sci 2016;5:425-432.
Curnow A, Owen SJ. An evaluation of root phytochemicals derived from althea officinalis (Marshmallow) and astragalus membranaceus as potential natural components of UV protecting dermatological formulations. Oxid Med Cell Longev 2016;2016:7053897.
Osbaldeston TA, Wood RP. Dioscorides: De materia medica. A new indexed translation in modern EnglishIbidis Press. Johannesburg 2000.
Kianitalaei A, Feyzabadi Z, Hamedi S, Qaraaty M. Althaea officinalis in traditional medicine and modern phytotherapy. J Adv Pharm Educ Res 2019;9:154-161.
Emamverdikhan AP, Golmakani N, Tabassi SA, Hassanzadeh M, Sharifi N, et al. A survey of the therapeutic effects of Vitamin E suppositories on vaginal atrophy in postmenopausal women. Iran J Nurs Midwifery Res 2016;21:475-481.
| Files | ||
| Issue | Vol 7, No 2, 2022 | |
| Section | Research Article(s) | |
| DOI | https://doi.org/10.18502/tim.v7i2.9916 | |
| Keywords | ||
| Menopause Vaginal atrophy Traditional persian medicine Herbal medicine Alcea angulata Phenolic compounds | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
